NIH-funded research R01 grant

Facet-driven low back pain: a targeted look at why pain varies between people

Official title: Facet-mediated Low back pain as a SubGroup for Studying Heterogeneity in Pain

Funded at University of Washington · NIH-11206071 · Data updated 2026-11-12

A large study focuses on people with facet-mediated persistent low back pain to understand why pain levels differ and how treatments work for different patients.

More Low Back Pain research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 8, 2026
Project endJune 30, 2030
Funding year2026
Award (this year)$4,635,617
NIH project number1R01AR086132-01
Project IDNIH-11206071 on NIH RePORTER

Who could benefit from this research

Could help

Adults with facet-mediated persistent low back pain who are willing to participate in observational assessments and model development.

Less likely to help

Patients without facet-mediated back pain or who are not eligible for observational cohorts may not benefit.

What this research studies

This project will recruit a well-defined group of adults with facet-mediated persistent low back pain to study why pain differs from person to person. Researchers will observe pain patterns and related factors, then validate findings in an existing clinical trial of 300 facet-mediated patients. They will build models to categorize patients by likely pain outcomes and identify what modifies treatment effects for lumbar spine therapies. The work aims to translate these insights into more personalized approaches for managing facet-related back pain.

Why it matters

Potential benefit: If successful, patients could receive more tailored treatment plans based on their pain profile and likely response to therapies.

How similar studies have gone: Previous research has begun to uncover subgroups in back pain, but this project advances subgroup modeling in facet-mediated pain specifically.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Rundell, Sean Daniel — University of Washington
  • Study coordinator: Rundell, Sean Daniel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.